2026 жылында Италияда аорталық қақпақты транскатетерлi имплантациялауға (TAVI) бойынша ең жақсы бағалар мен клиникалар туралы біліңіз

In Italy, eligibility for TAVI focuses on patients with symptomatic severe aortic stenosis who face high surgical risks. Candidates are generally aged 75 or older. However, clinical teams now consider patients as young as 70 depending on their specific health profile and anatomical suitability.

• Age criteria: Standard for patients over 75. New guidelines include those aged 70 and above.
• Surgical risk: Primarily for patients with high EuroSCORE II or prohibitive open-surgery risks.
• Anatomical feasibility: Requires favorable vascular access for the transfemoral approach through the leg.
• Life expectancy: Patients must have at least one year of expected life with better quality.

Bookimed Expert Insight: Italian centers like Maria Cecilia Hospital manage over 15% of national cardiac surgeries. Their Heart Teams prioritize TAVI for patients with prior bypass surgery or limited mobility. Specialized surgeons like Dr. Fausto Castriota lead clinical trials to expand eligibility safely. This high volume ensures better outcomes for complex, intermediate-risk cases.

Patient Consensus: High-risk patients over 80 often receive approval quickly in the public system. Younger candidates or those with previous surgeries often seek second opinions at private hospitals to speed up the process.

TAVI in Italy maintains a procedural success rate between 93.5% and 95%. Low-risk patients specifically reach efficacy levels of 95%. This minimally invasive procedure is highly standard across 97 specialized catheterization labs, with femoral access used in 90% of Italian cases to ensure optimal outcomes.

• Short-term survival: The 30-day all-cause mortality rate remains low at approximately 2.0%.
• Access method: Femoral approaches correlate with higher success and significantly lower 30-day mortality.
• Regional leaders: High-volume centers in Lombardy, Tuscany, and Veneto demonstrate the most consistent results.
• Safety benchmarks: Recent registry data confirms in-hospital mortality frequently stays below 2%.

Bookimed Expert Insight: Italian centers like Maria Cecilia Hospital demonstrate elite experience by handling over 15% of the country's total cardiac surgeries. Specialized clinics often involve lead investigators like Dr. Fausto Castriota, who focuses on brain protection during TAVI. Choosing a high-volume facility with JCI or IRCCS accreditation ensures the procedure is backed by active research and advanced protective protocols.

Patient Consensus: Most patients report returning to normal activity within weeks, though many emphasize asking about valve sizing upfront to avoid fatigue from paravalvular leaks. Others highlight the importance of 1-month follow-up echoes to monitor for subtle leaks.

Common risks of TAVI in Italy include conduction disturbances requiring permanent pacemakers in 13% to 23% of cases and vascular complications in 13% of patients. Specialized heart teams at JCI-accredited facilities monitor for paravalvular leakage, stroke, and major bleeding to ensure high technical success rates.

• Conduction issues: Approximately 13% to 23% of cases require a permanent pacemaker implantation.
• Vascular events: Vascular complications occur in 13% of patients, with 5% being major.
• Neurological safety: Stroke or transient ischemic attacks are reported in approximately 3% of cases.
• Paravalvular leakage: Significant leakage around the new valve occurs in roughly 4% of patients.

Bookimed Expert Insight: Italian cardiac centers like Maria Cecilia Hospital manage over 15% of the country's heart surgeries. This high volume allows multidisciplinary heart teams to refine patient selection. Data shows that mid-term mortality risks are often linked to pre-existing conditions rather than the procedure itself. Choosing a research-accredited IRCCS facility ensures access to the latest valve durability protocols.

Patient Consensus: Patients often emphasize the relief of undergoing a minimally invasive procedure instead of open-heart surgery. Many report that specialized mobility aids and early rehabilitation help them regain independence within the first month.

Recovery after TAVI in Italy generally permits hospital discharge within 1 to 3 days. Most patients return to light activities within 2 weeks after this minimally invasive cardiac procedure. Full recovery typically occurs within 4 to 6 weeks as energy levels stabilize and catheter sites heal.

• Hospital stay: Patients remain monitored for 1 to 3 days before standard home discharge.
• Immediate activity: Walking can begin on day 1 to assist circulation and speed recovery.
• Daily routine: Light activities and desk work are usually safe within 1 to 2 weeks.
• Full healing: Complete stabilization and return to strenuous activities takes 4 to 6 weeks.

Bookimed Expert Insight: Italian centers like Maria Cecilia Hospital handle over 15% of the country cardiac surgeries. This high volume often leads to faster recovery due to specialized post-op nursing. Some clinics include brain protection tech during TAVI, which can help minimize neurological fatigue during your first week home.

Patient Consensus: Many patients report walking the same day of the procedure. While groin bruising is common, the quick return to light tasks within a week is a significant relief.

Leading Italian centers for TAVI are concentrated in Milan, Rome, and Bologna, featuring JCI-accredited facilities and high procedural volumes. Major hubs like San Raffaele and Maria Cecilia Hospital perform a high percentage of Italy heart surgeries, utilizing expert Heart Teams and advanced protected TAVR technology.

• Top cardiac volume: Maria Cecilia Hospital handles over 15% of all Italian cardiac surgeries annually.
• Specialized TAVI leadership: Dr. Fausto Castriota leads brain-protection TAVR studies at Maria Cecilia Hospital.
• Academic excellence: IRCCS Ospedale Galeazzi - Sant'Ambrogio in Milan holds prestigious Italian Ministry Health accreditation.
• Southern Italy hub: Ospedale Santa Maria in Bari offers minimally invasive valve surgery under Prof. Giuseppe Speziale.

Bookimed Expert Insight: While Milan and Rome are popular, Bologna's Maria Cecilia Hospital stands out for specialized safety. It is a primary European site for protected TAVR research using brain-protection devices. This focus on preventing procedural stroke makes it a superior choice for high-risk patients seeking maximum safety.

Patient Consensus: Patients prioritize high-volume centers with over 100 procedures yearly to ensure better valve durability. Many choose private routes in Milan or Rome to bypass long public waiting lists for surgery.

Italy is a major hub for transcatheter aortic valve implantation (TAVI), performing nearly 19,000 annual procedures across 97 specialized centers. Ranking second in Europe for volume, the country handles 15% of regional implants, with high concentrations of expertise in Lombardy, Veneto, and Piedmont.

• National volume: Italy recorded 18,773 transcatheter heart valve procedures annually as of 2022.
• Clinical infrastructure: At least 97 catheterization labs provide TAVI services throughout the Italian territory.
• Regional leaders: Lombardy leads with 144 procedures per million inhabitants in northern high-volume centers.
• Surgical share: Maria Cecilia Hospital alone handles over 15% of all cardiac surgeries in Italy.

Bookimed Expert Insight: While northern Italy has the highest volume, patients should look for centers utilizing a Heart Team approach. Maria Cecilia Hospital uses this multidisciplinary method and participates in Protected TAVR studies. This focus on brain protection during valve deployment signifies a higher level of specialized care than standard centers.

The standard access route for TAVI in Italy is the transfemoral approach, utilized in approximately 90% of cases nationwide. This minimally invasive technique involves inserting the replacement valve through the femoral artery in the groin, typically performed under local anesthesia or conscious sedation.

• Gold standard: Transfemoral access is preferred for its minimally invasive nature and faster recovery.
• Success rate: High-volume Italian centers achieve over 95% success with the transfemoral approach.
• Hospital stay: Patients are typically discharged within 2 to 3 days after transfemoral TAVI.
• Alternative routes: Surgeons use subclavian or direct aortic access if femoral vessels are calcified.

Bookimed Expert Insight: Italian centers like Maria Cecilia Hospital handle over 15% of national cardiac surgeries, concentrating expertise in complex cases. Leading surgeons like Dr. Fausto Castriota focus on protective studies to reduce brain complications during TAVI. Choosing these high-volume facilities often ensures access to refined techniques like ultrasound-guided puncture, which prevents vascular injuries in calcified arteries.

Patient Consensus: Most patients expect a quick 3-day discharge but should prepare for potential shoulder pain if the subclavian route is used as an alternative. Extensive pre-operative CT scans are vital to ensure the femoral arteries can safely accommodate the delivery catheter.